See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rilutek
What is Riluzole? Riluzole is the first drug to be approved for ALS. Riluzole, available as RilutekĀ®, does not cure ALS or improve symptoms, but may extend the survival of patients by approximately three months. It appears to be more effective in patients with bulbar-onset than for those with limb-onset.
See more information, including instructions, precautions, side effects, and interactions.
1 patients in the community are taking or have taken Riluzole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 1 | 100% |
Based on the patients currently taking Riluzole.
| 100 mg Daily | ||
|---|---|---|
|
1
|
||